Platelet function monitoring in patients on clopidogrel

Author:

Aradi Dániel12,Rideg Orsolya3,Komócsi András1

Affiliation:

1. 1 Division of Interventional Cardiology, University of Pécs, Heart Institute, Pécs, Hungary

2. 3 Heart Centre, University of Pécs, Ifjúság u. 13, H-7624, Pécs, Hungary

3. 2 Institute of Laboratory Medicine, University of Pécs, Pécs, Hungary

Abstract

Abstract Clopidogrel is essential to prevent recurrent ischemic events in patients with acute coronary syndromes and after percutaneous coronary interventions (PCIs). However, platelet reactivity after clopidogrel treatment is not uniform, and high on-treatment platelet reactivity (HTPR) persists in approximately one third of patients receiving clopidogrel. As recent observational studies suggest that HTPR is associated with higher risk of ischemic events, including cardiovascular death, myocardial infarction and stent thrombosis, it seems rational to monitor post-clopidogrel platelet reactivity for risk assessment and to tailor anti-platelet therapy for patients with HTPR. However, routine platelet function monitoring is not recommended by current clinical guidelines. The article aims to review the available evidence on the clinical relevance of platelet function monitoring, highlighting possible reasons for the conflict between guidelines and observational studies.

Publisher

Akademiai Kiado Zrt.

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3